U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088250) titled 'Statins for Treatment of Primary Intracerebral Hemorrhage' on July 20.
Brief Summary: The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.
Study Start Date: May 06, 2023
Study Type: INTERVENTIONAL
Condition:
Cerebrovascular Disorders
Intracranial Hemorrhages
Intracranial Hemorrhage
Intracerebral Haemorrhage
Intervention:
DRUG: Atorvastatin Treatment
Atorvastatin 20 mg once daily for 21 days.
OTHER: Best Medical Treatme...